Vliyanie rozuvastatina na strukturnofunktsional'noe sostoyanie endoteliya u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu ishemicheskoy etiologii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Causes of endothelial dysfunction in chronic heart failure (CHF) are diverse and are associated with a long-term hemodynamic overload conducting arteries, hyperactivation of the renin-angiotensin-aldosterone and sympathetic-adrenal system, which manifests itself a perversion of endothelial dilating response to ordinary stimuli. The aim of the work was to study the structure of endothelial function in patients with chronic heart failure of ischemic etiology during therapy with rosuvastatin. The study found that patients with maladaptive remodeling and CHD, there is a marked vascular remodeling, which manifests itself by a sharp decline in vasoregulating endothelial function. In patients receiving rosuvastatin at a daily dose of 20 mg in patients with chronic heart failure of ischemic etiology in 3 months is a significant improvement in vasoregulating endothelial function, lipid profile and structural parameters of functional cardiac remodeling.

Full Text

Restricted Access

References

  1. Furchgott R.F., Zawadzki J.V. The obligatory role of the endothelil cells in relaxation of arterial smooth muscle by acetylholine. Nature 1980;288:373-76.
  2. Аронов Д.М. Каскад терапевтических эффектов статинов // Кардиология 2004. № 10. С. 85-94.
  3. Кулев Б.Д., Агеев Ф.Т. Влияние различных подходов терапии статинами у пациентов высокого риска с точки зрения сосудистого эндотелия // Кардиология. 2009. № 5. С. 4-10.
  4. Аронов Д.М. Плейотропные эффекты статинов // Кардиология. 2008. № 8. С. 60-8.
  5. Taniguchi K., Kavamoto T., Kuki S., et al. Left ventricular miokardial remodeling and contractile state in chronic aortic regurgitation. Clin Cardiol 2000;23:608-14.
  6. Celermajer D.S., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-15.
  7. Мареев В.Ю., Агеев Ф.Т и др. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). М., 2010.
  8. Huang A.L., Silver A.E., et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 2007;27:2065-67.
  9. Prasad A., Husain S., et al. Coronary endothelial dysfunction in humans improves with angiotension converting enzyme inhibition. Circulation 1996;94(Suppl. 1) abstr. 1:61.
  10. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Эндотелиальная дисфункция при сердечной недостаточности: возможности терапии ингибиторами ангиотензинпревращающего фермента // Кардиология. 2001. № 41(5). С. 100-4.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies